8-iso-13,14-dihydro-15-keto Prostaglandin F2α – 1 mg

Brand:
Cayman
CAS:
191919-02-5
Storage:
-20
UN-No:
De Minimis - 1231 / 3

8-iso-13,14-dihydro-15-keto Prostaglandin F2α (8-iso-13,14-dihydro-15-keto PGF2α) is a metabolite of the isoprostane, 8-isoprostane (8-iso PGF2α), in rabbits, monkeys and humans.{6907} 8-iso PGF2α is a PG-like product of non-specific lipid peroxidation.{320} In both humans and monkeys, exogenously infused 8-isoprostane is converted primarily to metabolites having 2 or 4 carbon atoms removed from the top side chain by β-oxidation.{6907} A similar pattern is observed when tritiated 8-isoprostane is infused into rabbits.{11209} Early in the infusion (within 10 minutes) 8-iso-13,14-dihydro-15-keto PGF2α was a significant component of the metabolite profile, which was comprised mostly of dinor 8-isoprostane metabolites. 8-iso-13,14-dihydro-15-keto PGF2α weakly inhibits the U-46619 or collagen-induced aggregation of human platelets, although a number of the E-series isoprostanes are much more potent in this assay.{11145}  

 

Out of stock

SKU: - Category:

Description

A metabolite of 8-iso PGF2α in rabbits, monkeys, and humans


Formal name: 9α,11α-dihydroxy-15-oxo-(8β)-prost-5Z-en-1-oic acid

Synonyms:  8-iso-13,14-dihydro-15-keto PGF2α

Molecular weight: 354.5

CAS: 191919-02-5

Purity: ≥98%

Formulation: A solution in methyl acetate


Product Type|Biochemicals|Lipids|Isoprostanes||Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Lipid Biochemistry|Reactive O2/N2 Pathways||Research Area|Oxidative Stress & Reactive Species|Lipid Peroxidation